140 related articles for article (PubMed ID: 34777591)
1. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma.
Ding Q; Lin D; Zhou Y; Li F; Lai J; Duan J; Chen J; Jiang C
Oncol Lett; 2021 Dec; 22(6):857. PubMed ID: 34777591
[TBL] [Abstract][Full Text] [Related]
2. AOC1 Contributes to Tumor Progression by Promoting the AKT and EMT Pathways in Gastric Cancer.
Xu F; Xu Y; Xiong JH; Zhang JH; Wu J; Luo J; Xiong JP
Cancer Manag Res; 2020; 12():1789-1798. PubMed ID: 32210620
[TBL] [Abstract][Full Text] [Related]
3. Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer.
Liu F; Ou W; Tang W; Huang Z; Zhu Z; Ding W; Fu J; Zhu Y; Liu C; Xu W; Du P
Front Oncol; 2021; 11():657210. PubMed ID: 34026633
[TBL] [Abstract][Full Text] [Related]
4. Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.
Kirschner KM; Braun JF; Jacobi CL; Rudigier LJ; Persson AB; Scholz H
J Biol Chem; 2014 Aug; 289(35):24452-62. PubMed ID: 25037221
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
[TBL] [Abstract][Full Text] [Related]
7. CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway.
Liu X; Zhao D
Anim Cells Syst (Seoul); 2021; 25(4):227-234. PubMed ID: 34408811
[TBL] [Abstract][Full Text] [Related]
8. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
[TBL] [Abstract][Full Text] [Related]
9. SOX15 transcriptionally increases the function of AOC1 to modulate ferroptosis and progression in prostate cancer.
Ding Y; Feng Y; Huang Z; Zhang Y; Li X; Liu R; Li H; Wang T; Ding Y; Jia Z; Yang J
Cell Death Dis; 2022 Aug; 13(8):673. PubMed ID: 35922412
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
[TBL] [Abstract][Full Text] [Related]
11. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
Gu FM; Li QL; Gao Q; Jiang JH; Zhu K; Huang XY; Pan JF; Yan J; Hu JH; Wang Z; Dai Z; Fan J; Zhou J
Mol Cancer; 2011 Dec; 10():150. PubMed ID: 22171994
[TBL] [Abstract][Full Text] [Related]
12. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1.
Wang J; Li H; Xia C; Yang X; Dai B; Tao K; Dou K
Onco Targets Ther; 2019; 12():869-882. PubMed ID: 30774374
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
15. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
Kang JH; Li MJ; Luan PP; Jiang DK; Chen YW; Xu X; Yu Q; Xu YW; Su Q; Peng WH; Jian WX
Cell Biol Int; 2020 Oct; 44(10):2053-2064. PubMed ID: 32584509
[TBL] [Abstract][Full Text] [Related]
16. RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells.
Xie C; Cao K; Peng D; Qin L
Exp Ther Med; 2021 Jul; 22(1):752. PubMed ID: 34035849
[TBL] [Abstract][Full Text] [Related]
17. The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.
Lin Y; Jin H; Wu X; Jian Z; Zou X; Huang J; Guan R; Wei X
Aging (Albany NY); 2020 Jul; 12(14):14391-14405. PubMed ID: 32716315
[TBL] [Abstract][Full Text] [Related]
18. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
